Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Oct;82(3):184-9.
doi: 10.1532/IJH97.05067.

Dyskeratosis congenita: a disorder of defective telomere maintenance?

Affiliations
Review

Dyskeratosis congenita: a disorder of defective telomere maintenance?

Amanda J Walne et al. Int J Hematol. 2005 Oct.

Abstract

Dyskeratosis congenita (DC) is a rare multisystem bone marrow failure syndrome that displays marked clinical and genetic heterogeneity. X-linked recessive, autosomal dominant and autosomal recessive forms of the disease are recognized. The gene that is mutated in the X-linked form of the disease is DKC1. The DKC1-encoded protein, dyskerin, is a component of small nucleolar ribonucleoprotein particles, which are important in ribosomal RNA processing, and of the telomerase complex. The autosomal dominant form of DC is due to mutations in the gene for the RNA component of telomerase (TERC). Because both dyskerin and TERC are components of the telomerase complex and all patients with DC have short telomeres, the principal pathology of DC appears to relate to telomerase dysfunction, although defects in ribosomal processing via dyskerin's involvement in pseudouridylation cannot be completely ruled out. The gene or genes involved in autosomal recessive DC remain elusive, although genes whose products are required for telomere maintenance remain strong candidates. The study of DC highlights the importance of telomerase in humans and how its deficiency results in multiple abnormalities, including premature aging, bone marrow failure, and cancer.

PubMed Disclaimer

References

    1. Blood. 2003 Aug 1;102(3):916-8 - PubMed
    1. Genes Dev. 1998 Feb 15;12(4):527-37 - PubMed
    1. Cancer Lett. 2003 May 15;194(2):189-97 - PubMed
    1. Lancet. 2003 Nov 15;362(9396):1628-30 - PubMed
    1. Br J Haematol. 2000 Sep;110(4):768-79 - PubMed

Publication types

MeSH terms